Comments
Loading...
Verve Therapeutics (VERV) Forecast
NewsEarningsVerve Therapeutics (VERV) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestVerve Therapeutics (NASDAQ:VERV) Stock Quotes, Forecast and News Summary
Verve Therapeutics Stock (NASDAQ: VERV) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Verve Therapeutics (VERV) stock?
You can purchase shares of Verve Therapeutics (NASDAQ:VERV) through any online brokerage.
Who are Verve Therapeutics (VERV) competitors?
There are no as such competitors for Verve Therapeutics.
What is the forecast, or price target, for Verve Therapeutics (VERV) stock?
Verve Therapeutics has a consensus price target of $31.78.
What is the current price for Verve Therapeutics (VERV)?
The stock price for Verve Therapeutics (NASDAQ: VERV) is $8.08 last updated February 4, 2025 at 3:32 PM EST.
Does Verve Therapeutics (VERV) pay a dividend?
There are no upcoming dividends for Verve Therapeutics.
When is Verve Therapeutics (NASDAQ:VERV) reporting earnings?
Verve Therapeutics’s Q4 earnings are confirmed for Tuesday, February 25, 2025.
Is Verve Therapeutics (VERV) going to split?
There is no upcoming split for Verve Therapeutics.
What sector and industry does Verve Therapeutics (VERV) operate in?
Verve Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.